Verastem, Inc. (VSTM): Price and Financial Metrics


Verastem, Inc. (VSTM): $3.17

-0.03 (-0.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VSTM to Watchlist
Sign Up

Industry: Biotech


Ranked

of 504

in industry

VSTM POWR Grades


  • Value is the dimension where VSTM ranks best; there it ranks ahead of 68.75% of US stocks.
  • The strongest trend for VSTM is in Momentum, which has been heading down over the past 48 weeks.
  • VSTM's current lowest rank is in the Momentum metric (where it is better than 9.5% of US stocks).

VSTM Stock Summary

  • With a year-over-year growth in debt of -60.48%, Verastem Inc's debt growth rate surpasses just 6.46% of about US stocks.
  • Revenue growth over the past 12 months for Verastem Inc comes in at 266.45%, a number that bests 97.08% of the US stocks we're tracking.
  • The volatility of Verastem Inc's share price is greater than that of 84.16% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Verastem Inc are EPZM, KOPN, ENTX, SDGR, and TTOO.
  • Visit VSTM's SEC page to see the company's official filings. To visit the company's web site, go to www.verastem.com.

VSTM Valuation Summary

  • In comparison to the median Healthcare stock, VSTM's EV/EBIT ratio is 149.15% lower, now standing at -14.4.
  • Over the past 117 months, VSTM's price/sales ratio has gone NA NA.
  • VSTM's price/sales ratio has moved NA NA over the prior 117 months.

Below are key valuation metrics over time for VSTM.

Stock Date P/S P/B P/E EV/EBIT
VSTM 2021-08-31 5.9 5.4 -12.4 -14.4
VSTM 2021-08-30 6.0 5.5 -12.5 -14.5
VSTM 2021-08-27 6.2 5.7 -12.9 -15.0
VSTM 2021-08-26 5.8 5.3 -12.2 -14.1
VSTM 2021-08-25 6.1 5.5 -12.6 -14.6
VSTM 2021-08-24 5.9 5.4 -12.3 -14.3

VSTM Growth Metrics

  • Its 5 year cash and equivalents growth rate is now at 750.06%.
  • Its 4 year net cashflow from operations growth rate is now at -199.51%.
  • The 5 year net cashflow from operations growth rate now stands at -197.13%.
VSTM's revenue has moved up $80,659,000 over the prior 52 months.

The table below shows VSTM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 80.659 -9.698 -38.659
2021-03-31 84.466 -18.821 -44.767
2020-12-31 88.516 -33.506 -67.726
2020-09-30 91.626 -49.024 -86.636
2020-06-30 22.011 -121.619 -129.913
2020-03-31 20.84 -133.741 -149.097

VSTM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VSTM has a Quality Grade of C, ranking ahead of 61.79% of graded US stocks.
  • VSTM's asset turnover comes in at 0.51 -- ranking 83rd of 677 Pharmaceutical Products stocks.
  • SVRA, SESN, and EDIT are the stocks whose asset turnover ratios are most correlated with VSTM.

The table below shows VSTM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.510 0.602 -0.382
2021-03-31 0.478 0.611 -0.535
2020-12-31 0.455 0.619 -0.911
2020-09-30 0.476 0.624 -1.030
2020-06-30 0.118 0.856 -1.060
2020-03-31 0.109 0.849 -0.900

VSTM Price Target

For more insight on analysts targets of VSTM, see our VSTM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.25 Average Broker Recommendation 1.38 (Strong Buy)

VSTM Stock Price Chart Interactive Chart >

Price chart for VSTM

VSTM Price/Volume Stats

Current price $3.17 52-week high $4.93
Prev. close $3.20 52-week low $1.14
Day low $3.13 Volume 2,393,117
Day high $3.27 Avg. volume 2,778,082
50-day MA $2.92 Dividend yield N/A
200-day MA $2.90 Market Cap 573.00M

Verastem, Inc. (VSTM) Company Bio


Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.


VSTM Latest News Stream


Event/Time News Detail
Loading, please wait...

VSTM Latest Social Stream


Loading social stream, please wait...

View Full VSTM Social Stream

Latest VSTM News From Around the Web

Below are the latest news stories about Verastem Inc that investors may wish to consider to help them evaluate VSTM as an investment opportunity.

Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer

BOSTON, September 22, 2021--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of Louis J. Denis, M.D., as Chief Medical Officer. Dr. Denis brings more than 25 years of clinical development and oncology expertise to Verastem.

Yahoo | September 22, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back, trader!

William White on InvestorPlace | September 20, 2021

13 Stocks Taking the Biggest Hit Today From China’s Evergrande Collapse

Several stocks are taking a beating on Monday as news of the China Evergrande Group debt fiasco continues to unfold today.

William White on InvestorPlace | September 20, 2021

EA Stock News: 7 Things to Know About the $1.4B Electronic Arts-Playdemic Deal

Electronic Arts (EA) stock is dipping as it beefs up its mobile game with the $1.4 billion acquisition of developer Playdemic from AT&T (T).

William White on InvestorPlace | September 20, 2021

Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher

Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN).

William White on InvestorPlace | September 20, 2021

Read More 'VSTM' Stories Here

VSTM Price Returns

1-mo 17.41%
3-mo -26.45%
6-mo 28.34%
1-year 161.98%
3-year -55.66%
5-year 126.43%
YTD 48.83%
2020 58.96%
2019 -60.12%
2018 9.45%
2017 174.11%
2016 -39.78%

Continue Researching VSTM

Here are a few links from around the web to help you further your research on Verastem Inc's stock as an investment opportunity:

Verastem Inc (VSTM) Stock Price | Nasdaq
Verastem Inc (VSTM) Stock Quote, History and News - Yahoo Finance
Verastem Inc (VSTM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9392 seconds.